Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp167 | Obesity (1) | ECE2019

Epigenetic regulation by miRNAs in corticotroph tumors

Garcia-Martinez Araceli , Lopez-Munoz Beatriz , Fajardo Carmen , Camara Rosa , Lamas Cristina , Torregrosa Maria Eugenia , Aranda Ignacio , Pico Antonio

Introduction: The silencing mechanisms of corticotroph tumors (CT) remain unclear. The most feasible hypothesis lies in a post-transcriptional deregulation of the POMC gene, precursor of ACTH. Micro RNAs (miRNAs) are small non-coding RNA molecules involved in the epigenetic regulation of gene expression through their inhibitory action on messenger RNA. miRNAs capable of inhibiting the expression of POMC have been described at the level of neurons of the hypot...

ea0063gp207 | Diabetes: Pharmacotherapy | ECE2019

Treatment with sitagliptin in patients with type 1 diabetes and type LADA diabetes

Moreno-Moreno Paloma , Alhambra-Exposito Maria Rosa , Rebollo-Roman Angel , Martin-Barrera Ana , Galvez-Moreno Maria Angeles

Objective: Preclinical studies have shown that DPP-4 inhibitors (iDPP4) have beneficial effects on functional mass of beta cells and pancreatic insulin content. The aim of this study is to evaluate the efficacy of treatment with sitagliptin in monotherapy or in combination with insulin in person with type 1 diabetes (DM-1) or type LADA diabetes (DM-LADA) of recent diagnosis.Patients and methods: Descriptive study: patients with DM-1 or DM-LADA in treatme...

ea0063p80 | Calcium and Bone 1 | ECE2019

Effects of bariatric surgery on bone health

Exposito Maria Rosa Alhambra , Martin Ana Barrera , Jimenez Concepcion Munoz , Puerta Maria Jose Molina , Moreno Maria Angeles Galvez

Introduction: Bariatric surgery has important metabolic complications such as bone mass loss.Goal: To assess bone mineral density (BMD) after Roux-en-Y gastric by-pass (RYGB) in patients under standard calcium and vitamin D supplementation.Method: In patients with morbid obesity submitted to RYGB, we measured BMD with a dual X-ray densitometer. Using World Health Organization (WHO) criteria’s, values were compared with young c...

ea0063p181 | Diabetes, Obesity and Metabolism 1 | ECE2019

Gestational diabetes mellitus and continuous glucose monitoring: glycemic patterns and pregnancy outcomes

Rosa Marquez-Pardo , Isabel Torres-Barea , Doncel Lourdes Garcia-Garcia , Concepcion Cruzado-Begines , Maria-Gloria Baena-Nieto

Introduction: Gestational diabetes mellitus (GDM) is associated with an increase risk of neonatal and maternal complications. Continuous glucose monitoring (CGM) detects glycemic patterns, which could help predict the development of maternal-fetal complications.Objective: To analyze the different glycemic patterns obtained with CGM and to correlate them with the appearance of maternal-fetal complications in GDM.Methods: Women with ...

ea0063p261 | Pituitary and Neuroendocrinology 1 | ECE2019

Novel insight into ACTH-secreting pituitary tumors biological behavior: somatostatin receptor type 5 (SST5) modulation by ubiquitin specific peptidase 8 (USP8)

Peverelli Erika , Treppiedi Donatella , Giardino Elena , Catalano Rosa , Mangili Federica , Vercesi Pietro , Locatelli Marco , Spada Anna , Arosio Maura , Mantovani Giovanna

Cushing’s Disease (CD) is a rare condition characterized by an overproduction of ACTH by an ACTH-secreting pituitary tumor, resulting in excess of cortisol release by the adrenal glands. Pasireotide is the pituitary-targeted drug approved to treat adult patients. Its mechanism of action seems to rely on the preferential binding to the highly expressed somatostatin receptor in corticotroph tumors, SST5. Recently, somatic mutations in the deubiquitinase USP8 gene h...

ea0063p265 | Pituitary and Neuroendocrinology 1 | ECE2019

Somatostatin receptor type 2 trafficking through the cytoskeleton: role of scaffolding proteins Filamin A and β-arrestin 2

Treppiedi Donatella , Giardino Elena , Catalano Rosa , Mangili Federica , Locatelli Marco , Spada Anna , Arosio Maura , Mantovani Giovanna , Peverelli Erika

The high expression of somatostatin receptor 2 (SST2) in growth hormone (GH)-secreting tumors represents the rationale for the clinical use of somatostatin analogs (SSAs) in acromegaly. However, about one third of patients displays resistance to SSAs and, to date, the responsible molecular mechanisms are still under investigation. Recently, the cytoskeletal protein Filamin A (FLNA) and the scaffolding proteins β-arrestins have emerged as key modulators of the responsivene...

ea0063p267 | Pituitary and Neuroendocrinology 1 | ECE2019

Somatostatin receptor type 5 modulation by Filamin A in ACTH-secreting pituitary tumors

Treppiedi Donatella , Giardino Elena , Catalano Rosa , Mangili Federica , Locatelli Marco , Spada Anna , Arosio Maura , Mantovani Giovanna , Peverelli Erika

Cushing’s disease (CD) is a rare disorder of chronic hypercortisolism due to an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor. Pasireotide, a multireceptor-targeted somatostatin (SST) analog with high binding affinity for the predominant SST receptor in human corticotroph tumors, SST5, has been recently approved to treat adult patients for whom surgery failed or does not represent a suitable option. However, to date, the molecular predictors of antisecretor...

ea0063p390 | Thyroid 1 | ECE2019

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

Giardino Elena , Catalano Rosa , Barbieri Annamaria , Treppiedi Donatella , Mangili Federica , Spada Anna , Arosio Maura , Mantovani Giovanna , Peverelli Erika

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor that originates from parafollicular thyroid C cells and accounts for 5% -10% of thyroid cancers. In all inherited cases of MTC, and in about 40% of sporadic cases, activating mutations of the receptor tyrosine kinase proto-oncogene RET are found. Constitutively active RET triggers signaling pathways involved in cell proliferation, survival and motility, but the mechanisms underlying malignant transformation of C-...

ea0063p715 | Pituitary and Neuroendocrinology 2 | ECE2019

Silent somatotroph tumors

Garcia-Martinez Araceli , Lloret Adriana , Torregrosa Maria Eugenia , Silva Sandra , Lamas Cristina , Fajardo Carmen , Camara Rosa , Aranda Ignacio , Pico Antonio

Introduction: Silent somatotroph tumors (sST) are a pituitary neuroendocrine tumor subtype with positive immunostaining for growth hormone (GH) but without the presence of acromegaly. Unlike silent corticotroph tumors, there is little information in the literature on sST. The aim of the present study was to study the demographic, clinical and molecular characteristics in a series of ST in order to compare sST and functioning ST (fST).Methods: We have stu...

ea0063p793 | Thyroid 2 | ECE2019

Follicular lesion of undetermined thyroid significance: therapeutic approach to the diagnosis of bethesda 3

Martin Ana Barrera , Exposito Maria Rosa Alhambra , Roman Angel Rebollo , Azpilcueta Pedro Segui , Moreno Maria Angeles Galvez

Introduction: Thyroid nodules are very common in the general population (20–75% ultrasound). There are clinical management criteria established by international societies and standardized cytological diagnostic criteria (Bethesda). However, there is still uncertainty in the management of category 3 (follicular lesion of undetermined significance). Objectives: To evaluate the clinical attitude to the cytological diagnosis of Bethesda category 3 (B3) in thyroid fine-needle ...